These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 23011353)

  • 1. Effect of a common variant of the PCSK2 gene on reduced insulin secretion.
    Jonsson A; Isomaa B; Tuomi T; Eriksson JG; Groop L; Lyssenko V
    Diabetologia; 2012 Dec; 55(12):3245-51. PubMed ID: 23011353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variant in the KCNQ1 gene predicts future type 2 diabetes and mediates impaired insulin secretion.
    Jonsson A; Isomaa B; Tuomi T; Taneera J; Salehi A; Nilsson P; Groop L; Lyssenko V
    Diabetes; 2009 Oct; 58(10):2409-13. PubMed ID: 19584308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High normal HbA(1c) levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8).
    Heianza Y; Arase Y; Fujihara K; Tsuji H; Saito K; Hsieh SD; Kodama S; Shimano H; Yamada N; Hara S; Sone H
    Diabet Med; 2012 Oct; 29(10):1285-90. PubMed ID: 22486679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms of PCSK2 are associated with glucose homeostasis and progression to type 2 diabetes in a Chinese population.
    Chang TJ; Chiu YF; Sheu WH; Shih KC; Hwu CM; Quertermous T; Jou YS; Kuo SS; Chang YC; Chuang LM
    Sci Rep; 2015 Nov; 5():14380. PubMed ID: 26607656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of common sequence variants in insulin secretion in familial type 2 diabetic kindreds: the sulfonylurea receptor, glucokinase, and hepatocyte nuclear factor 1alpha genes.
    Elbein SC; Sun J; Scroggin E; Teng K; Hasstedt SJ
    Diabetes Care; 2001 Mar; 24(3):472-8. PubMed ID: 11289470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common variant upstream of the PAX6 gene influences islet function in man.
    Ahlqvist E; Turrini F; Lang ST; Taneera J; Zhou Y; Almgren P; Hansson O; Isomaa B; Tuomi T; Eriksson K; Eriksson JG; Lyssenko V; Groop L
    Diabetologia; 2012 Jan; 55(1):94-104. PubMed ID: 21922321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets.
    Yang BT; Dayeh TA; Kirkpatrick CL; Taneera J; Kumar R; Groop L; Wollheim CB; Nitert MD; Ling C
    Diabetologia; 2011 Feb; 54(2):360-7. PubMed ID: 21104225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of PCSK2 coding variants: A founder effect in the Old Order Amish population.
    Winters A; Ramos-Molina B; Jarvela TS; Yerges-Armstrong L; Pollin TI; Lindberg I
    Diabetes Res Clin Pract; 2017 Sep; 131():82-90. PubMed ID: 28719828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of FOXA2 rs1209523 on glucose-related phenotypes and risk of type 2 diabetes in Danish individuals.
    Banasik K; Hollensted M; Andersson E; Sparsø T; Sandbaek A; Lauritzen T; Jørgensen T; Witte DR; Pedersen O; Hansen T
    BMC Med Genet; 2012 Feb; 13():10. PubMed ID: 22325233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
    Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
    Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The associations of daylight and melatonin receptor 1B gene rs10830963 variant with glycemic traits: the prospective PPP-Botnia study.
    Haljas K; Hakaste L; Lahti J; Isomaa B; Groop L; Tuomi T; Räikkönen K
    Ann Med; 2019 Feb; 51(1):58-67. PubMed ID: 30592226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of glucose control with insulin sensitivity and pancreatic beta-cell responsiveness in newly presenting type 2 diabetes.
    Albarrak AI; Luzio SD; Chassin LJ; Playle RA; Owens DR; Hovorka R
    J Clin Endocrinol Metab; 2002 Jan; 87(1):198-203. PubMed ID: 11788647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients.
    Kruszynska YT; Goulas S; Wollen N; McIntyre N
    J Hepatol; 1998 Feb; 28(2):280-91. PubMed ID: 9514541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
    Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
    Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment by post-challenge plasma glucose, insulin response ratio, and other indices of insulin resistance and/or secretion for predicting the development of type 2 diabetes.
    Tanabe N; Saito K; Yamada Y; Takasawa T; Seki N; Suzuki H
    Intern Med; 2009; 48(6):401-9. PubMed ID: 19293537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A common genetic variant in WFS1 determines impaired glucagon-like peptide-1-induced insulin secretion.
    Schäfer SA; Müssig K; Staiger H; Machicao F; Stefan N; Gallwitz B; Häring HU; Fritsche A
    Diabetologia; 2009 Jun; 52(6):1075-82. PubMed ID: 19330314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with Type II diabetes mellitus.
    Hart LM; Dekker JM; van Haeften TW; Ruige JB; Stehouwer CD; Erkelens DW; Heine RJ; Maassen JA
    Diabetologia; 2000 Apr; 43(4):515-9. PubMed ID: 10819247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon-stimulated insulin secretion in patients with type 2 diabetes mellitus: support for the concept of glucose toxicity.
    Wolffenbuttel BH; Menheere PP; Nijst L; Rondas-Colbers GJ; Sels JP; Nieuwenhuijzen Kruseman AC
    Neth J Med; 1992 Jun; 40(5-6):277-82. PubMed ID: 1436266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased insulin secretion and increased risk of type 2 diabetes associated with allelic variations of the WFS1 gene: the Data from Epidemiological Study on the Insulin Resistance Syndrome (DESIR) prospective study.
    Cheurfa N; Brenner GM; Reis AF; Dubois-Laforgue D; Roussel R; Tichet J; Lantieri O; Balkau B; Fumeron F; Timsit J; Marre M; Velho G
    Diabetologia; 2011 Mar; 54(3):554-62. PubMed ID: 21127832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.